Jon E. Angell

Array ( [id] => 7818005 [patent_doc_number] => 20120064625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'Nucleic Acids, Polypeptides, Compositions, and Methods for Modulating Apoptosis' [patent_app_type] => utility [patent_app_number] => 13/007137 [patent_app_country] => US [patent_app_date] => 2011-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 19499 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20120064625.pdf [firstpage_image] =>[orig_patent_app_number] => 13007137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6190012 [patent_doc_number] => 20110172296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'MODULATION OF TRANSFORMING GROWTH FACTOR-BETA 1 EXPRESSION' [patent_app_type] => utility [patent_app_number] => 13/005508 [patent_app_country] => US [patent_app_date] => 2011-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 32643 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20110172296.pdf [firstpage_image] =>[orig_patent_app_number] => 13005508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487555 [patent_doc_number] => 20110236427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'Antagonists of NR2F6 For Augmenting The Immune Response' [patent_app_type] => utility [patent_app_number] => 13/004781 [patent_app_country] => US [patent_app_date] => 2011-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 37998 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236427.pdf [firstpage_image] =>[orig_patent_app_number] => 13004781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8617328 [patent_doc_number] => 20130022640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-24 [patent_title] => 'IMMUNE MODULATORS RELATING TO FOXO3A' [patent_app_type] => utility [patent_app_number] => 13/520904 [patent_app_country] => US [patent_app_date] => 2011-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 23251 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13520904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9951356 [patent_doc_number] => 09000143 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-07 [patent_title] => 'Compositions and methods for inhibiting expression of IKK-B gene' [patent_app_type] => utility [patent_app_number] => 12/982261 [patent_app_country] => US [patent_app_date] => 2010-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 27538 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12982261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8674924 [patent_doc_number] => 08383036 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-26 [patent_title] => 'Methods for neutralizing anthrax or anthrax spores' [patent_app_type] => utility [patent_app_number] => 12/973681 [patent_app_country] => US [patent_app_date] => 2010-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 7859 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12973681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6185039 [patent_doc_number] => 20110123998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'Materials and Methods for Treatment of Cancer' [patent_app_type] => utility [patent_app_number] => 12/948648 [patent_app_country] => US [patent_app_date] => 2010-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16266 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20110123998.pdf [firstpage_image] =>[orig_patent_app_number] => 12948648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6120699 [patent_doc_number] => 20110077173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'siRNA targeting TIE-2' [patent_app_type] => utility [patent_app_number] => 12/927144 [patent_app_country] => US [patent_app_date] => 2010-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 36001 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20110077173.pdf [firstpage_image] =>[orig_patent_app_number] => 12927144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6117731 [patent_doc_number] => 20110191873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'Methods of Protein Destabilization and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/938179 [patent_app_country] => US [patent_app_date] => 2010-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 32164 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20110191873.pdf [firstpage_image] =>[orig_patent_app_number] => 12938179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8370245 [patent_doc_number] => 20120219632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'METHODS FOR MONITORING CELLULAR STATES AND FOR IMMORTALIZING MESENCHYMAL STEM CELL' [patent_app_type] => utility [patent_app_number] => 13/505622 [patent_app_country] => US [patent_app_date] => 2010-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 41196 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13505622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9762307 [patent_doc_number] => 08846630 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-30 [patent_title] => 'Pharmaceutical composition for treating cancer' [patent_app_type] => utility [patent_app_number] => 13/512583 [patent_app_country] => US [patent_app_date] => 2010-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 14 [patent_no_of_words] => 7470 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13512583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8336165 [patent_doc_number] => 20120202875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'Method Of Treatment' [patent_app_type] => utility [patent_app_number] => 13/500408 [patent_app_country] => US [patent_app_date] => 2010-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7364 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13500408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8313710 [patent_doc_number] => 20120190732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'Multifunctional Aptamer-Nucleic Acid Nanostructures for Tumor-Targeted Killing' [patent_app_type] => utility [patent_app_number] => 13/392735 [patent_app_country] => US [patent_app_date] => 2010-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16683 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13392735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9184075 [patent_doc_number] => 08624008 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-07 [patent_title] => 'Aptamer and detection method for C-reactive protein' [patent_app_type] => utility [patent_app_number] => 12/924225 [patent_app_country] => US [patent_app_date] => 2010-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7562 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12924225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4612121 [patent_doc_number] => 07988959 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-02 [patent_title] => 'Method of treatment using organotypically cultured skin tissue comprising niks cells that express exogenous HIF-1a' [patent_app_type] => utility [patent_app_number] => 12/886976 [patent_app_country] => US [patent_app_date] => 2010-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 21204 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/988/07988959.pdf [firstpage_image] =>[orig_patent_app_number] => 12886976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8294611 [patent_doc_number] => 08222396 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-17 [patent_title] => 'SiRNA targeting proto-oncogene MET' [patent_app_type] => utility [patent_app_number] => 12/807526 [patent_app_country] => US [patent_app_date] => 2010-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 34732 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12807526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5943549 [patent_doc_number] => 20110104169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'REGULATOR GENES OF ANGIOGENESIS, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THEIR APPLICATIONS' [patent_app_type] => utility [patent_app_number] => 12/870165 [patent_app_country] => US [patent_app_date] => 2010-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12423 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104169.pdf [firstpage_image] =>[orig_patent_app_number] => 12870165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4619377 [patent_doc_number] => 07999097 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-16 [patent_title] => 'siRNA targeting beta secretase (BACE)' [patent_app_type] => utility [patent_app_number] => 12/806570 [patent_app_country] => US [patent_app_date] => 2010-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 35010 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/999/07999097.pdf [firstpage_image] =>[orig_patent_app_number] => 12806570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6600824 [patent_doc_number] => 20100322905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'Compositions and methods for treating pancreatic cancer' [patent_app_type] => utility [patent_app_number] => 12/856954 [patent_app_country] => US [patent_app_date] => 2010-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6396 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0322/20100322905.pdf [firstpage_image] =>[orig_patent_app_number] => 12856954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6350939 [patent_doc_number] => 20100331214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'siRNA Targeting Survivin' [patent_app_type] => utility [patent_app_number] => 12/806513 [patent_app_country] => US [patent_app_date] => 2010-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 28803 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0331/20100331214.pdf [firstpage_image] =>[orig_patent_app_number] => 12806513 [rel_patent_id] =>[rel_patent_doc_number] =>)